{"pmid":32345750,"title":"Impending Shortages of Kidney Replacement Therapy for COVID-19 Patients.","text":["Impending Shortages of Kidney Replacement Therapy for COVID-19 Patients.","Clin J Am Soc Nephrol","Goldfarb, David S","Benstein, Judith A","Zhdanova, Olga","Hammer, Elizabeth","Block, Clay A","Caplin, Nina J","Thompson, Nathan","Charytan, David M","32345750"],"journal":"Clin J Am Soc Nephrol","authors":["Goldfarb, David S","Benstein, Judith A","Zhdanova, Olga","Hammer, Elizabeth","Block, Clay A","Caplin, Nina J","Thompson, Nathan","Charytan, David M"],"date":"2020-04-30T11:00:00Z","year":2020,"_id":"32345750","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.2215/CJN.05180420","keywords":["covid-19","renal replacement therapy","acute kidney injury","hemodialysis","intensive care medicine","kidney replacement","peritoneal dialysis","severe acute respiratory syndrome coronavirus 2"],"topics":["Prevention"],"weight":1,"_version_":1666138495409717249,"score":9.490897,"similar":[{"pmid":32489502,"pmcid":"PMC7239583","title":"COVID-19 and Renal Failure: Challenges in the Delivery of Renal Replacement Therapy.","text":["COVID-19 and Renal Failure: Challenges in the Delivery of Renal Replacement Therapy.","Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first officially reported in December 2019 in Wuhan City, Hubei province, China, and has since lead to a pandemic. Most cases result in minor symptoms such as cough, fever, sore throat, myalgia, fatigue, nausea, diarrhea, loss of smell, and abdominal pain. As of April 8, 2020, more than 1,485,000 cases of COVID-19 have been reported in more than 200 countries and territories, resulting in over 90,000 deaths. Outcomes are worse in elderly patients, particularly males, and those with comorbidities, but can affect any age group. The incidence of acute kidney injury in patients with COVID-19 infection is about 3-15%; and in patients with severe infection requiring care in the intensive care unit, the rates of acute kidney injury increased significantly from 15% to 50%. Acute kidney injury is an independent risk factor for mortality in COVID-19 patients. The nephrologists, as well as intensivists, are facing immense daily challenges while providing care for these patients in the inpatient setting as well as end-stage renal disease patients on chronic dialysis in both inpatient and outpatient settings. In the current review article, we discussed the epidemiology and etiology of acute kidney injury, management of acute kidney injury including renal replacement therapy options (both hemodialysis and peritoneal dialysis) for inpatient floor, as well as intensive care unit settings. We also discussed the challenges faced by the outpatient dialysis units with COVID-19 infection. We discussed measures required to limit the spread of infection, as well as summarized the guidance as per the Centers for Disease Control and Prevention (CDC), American Society of Nephrology (ASN), American Society of Diagnostic and Interventional Nephrology (ASDIN) and the Vascular Access Society of the Americas (VASA).","J Clin Med Res","Adapa, Sreedhar","Aeddula, Narothama Reddy","Konala, Venu Madhav","Chenna, Avantika","Naramala, Srikanth","Madhira, Bhaskar Reddy","Gayam, Vijay","Balla, Mamtha","Muppidi, Vijayadershan","Bose, Subhasish","32489502"],"abstract":["Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first officially reported in December 2019 in Wuhan City, Hubei province, China, and has since lead to a pandemic. Most cases result in minor symptoms such as cough, fever, sore throat, myalgia, fatigue, nausea, diarrhea, loss of smell, and abdominal pain. As of April 8, 2020, more than 1,485,000 cases of COVID-19 have been reported in more than 200 countries and territories, resulting in over 90,000 deaths. Outcomes are worse in elderly patients, particularly males, and those with comorbidities, but can affect any age group. The incidence of acute kidney injury in patients with COVID-19 infection is about 3-15%; and in patients with severe infection requiring care in the intensive care unit, the rates of acute kidney injury increased significantly from 15% to 50%. Acute kidney injury is an independent risk factor for mortality in COVID-19 patients. The nephrologists, as well as intensivists, are facing immense daily challenges while providing care for these patients in the inpatient setting as well as end-stage renal disease patients on chronic dialysis in both inpatient and outpatient settings. In the current review article, we discussed the epidemiology and etiology of acute kidney injury, management of acute kidney injury including renal replacement therapy options (both hemodialysis and peritoneal dialysis) for inpatient floor, as well as intensive care unit settings. We also discussed the challenges faced by the outpatient dialysis units with COVID-19 infection. We discussed measures required to limit the spread of infection, as well as summarized the guidance as per the Centers for Disease Control and Prevention (CDC), American Society of Nephrology (ASN), American Society of Diagnostic and Interventional Nephrology (ASDIN) and the Vascular Access Society of the Americas (VASA)."],"journal":"J Clin Med Res","authors":["Adapa, Sreedhar","Aeddula, Narothama Reddy","Konala, Venu Madhav","Chenna, Avantika","Naramala, Srikanth","Madhira, Bhaskar Reddy","Gayam, Vijay","Balla, Mamtha","Muppidi, Vijayadershan","Bose, Subhasish"],"date":"2020-06-04T11:00:00Z","year":2020,"_id":"32489502","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.14740/jocmr4160","keywords":["acute kidney injury","covid-19","end-stage renal disease","hemodialysis","hemofiltration","kidney impairment","peritoneal dialysis","renal replacement therapy"],"locations":["Wuhan","Hubei","China","myalgia","fatigue","diarrhea"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1668623433623142401,"score":220.82343},{"pmid":32503180,"title":"Fatal Outcomes of COVID-19 in Patients with Severe Acute Kidney Injury.","text":["Fatal Outcomes of COVID-19 in Patients with Severe Acute Kidney Injury.","The outcome of coronavirus disease 2019 (COVID-19) is associated with organ damage; however, the information about the relationship between acute kidney injury (AKI) and COVID-19 is still rare. We evaluated the clinical features and prognosis of COVID-19 patients with AKI according to the AKI severity. Medical data of hospitalized COVID-19 patients in two university-based hospitals during an outbreak in Daegu, South Korea, were retrospectively analyzed. AKI and its severity were defined according to the Acute Kidney Injury Network. Of the 164 hospitalized patients with COVID-19, 30 patients (18.3%) had AKI; 14, 4, and 12 patients had stage 1, 2, and 3, respectively. The median age was significantly higher in AKI patients than in non-AKI patients (75.5 vs. 67.0 years, p = 0.005). There were 17 deaths (56.7%) among AKI patients; 4 (28.6%), 1 (25.0%), and 12 (100.0%), respectively. In-hospital mortality was higher in AKI patients than in non-AKI patients (56.7% vs. 20.8%, p < 0.001). After adjusting for potential confounding factors, stage 3 AKI was associated with higher mortality than either non-AKI or stage 1 AKI (hazard ratio (HR) = 3.62 (95% confidence interval (CI) = 1.75-7.48), p = 0.001; HR = 15.65 (95% CI = 2.43-100.64), p = 0.004). Among the AKI patients, acute respiratory distress syndrome and low serum albumin on admission were considered independent risk factors for stage 3 AKI (both p < 0.05). Five patients with stage 3 AKI underwent dialysis and eventually died. In conclusion, COVID-19 patients with severe AKI had fatal outcomes.","J Clin Med","Lim, Jeong-Hoon","Park, Sun-Hee","Jeon, Yena","Cho, Jang-Hee","Jung, Hee-Yeon","Choi, Ji-Young","Kim, Chan-Duck","Lee, Yong-Hoon","Seo, Hyewon","Lee, Jaehee","Kwon, Ki Tae","Kim, Shin-Woo","Chang, Hyun-Ha","Kim, Yong-Lim","32503180"],"abstract":["The outcome of coronavirus disease 2019 (COVID-19) is associated with organ damage; however, the information about the relationship between acute kidney injury (AKI) and COVID-19 is still rare. We evaluated the clinical features and prognosis of COVID-19 patients with AKI according to the AKI severity. Medical data of hospitalized COVID-19 patients in two university-based hospitals during an outbreak in Daegu, South Korea, were retrospectively analyzed. AKI and its severity were defined according to the Acute Kidney Injury Network. Of the 164 hospitalized patients with COVID-19, 30 patients (18.3%) had AKI; 14, 4, and 12 patients had stage 1, 2, and 3, respectively. The median age was significantly higher in AKI patients than in non-AKI patients (75.5 vs. 67.0 years, p = 0.005). There were 17 deaths (56.7%) among AKI patients; 4 (28.6%), 1 (25.0%), and 12 (100.0%), respectively. In-hospital mortality was higher in AKI patients than in non-AKI patients (56.7% vs. 20.8%, p < 0.001). After adjusting for potential confounding factors, stage 3 AKI was associated with higher mortality than either non-AKI or stage 1 AKI (hazard ratio (HR) = 3.62 (95% confidence interval (CI) = 1.75-7.48), p = 0.001; HR = 15.65 (95% CI = 2.43-100.64), p = 0.004). Among the AKI patients, acute respiratory distress syndrome and low serum albumin on admission were considered independent risk factors for stage 3 AKI (both p < 0.05). Five patients with stage 3 AKI underwent dialysis and eventually died. In conclusion, COVID-19 patients with severe AKI had fatal outcomes."],"journal":"J Clin Med","authors":["Lim, Jeong-Hoon","Park, Sun-Hee","Jeon, Yena","Cho, Jang-Hee","Jung, Hee-Yeon","Choi, Ji-Young","Kim, Chan-Duck","Lee, Yong-Hoon","Seo, Hyewon","Lee, Jaehee","Kwon, Ki Tae","Kim, Shin-Woo","Chang, Hyun-Ha","Kim, Yong-Lim"],"date":"2020-06-07T11:00:00Z","year":2020,"_id":"32503180","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.3390/jcm9061718","keywords":["aki severity","covid-19","acute kidney injury","mortality","renal replacement therapy"],"locations":["Daegu","South Korea"],"countries":["Korea, Republic of"],"countries_codes":["KOR|Korea, Republic of"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1668892488337719296,"score":112.927124},{"pmid":32343085,"title":"Caring for Nephrology Patients and Staff During the COVID-19 Pandemic: Experiences of the Northwest Kidney Centers.","text":["Caring for Nephrology Patients and Staff During the COVID-19 Pandemic: Experiences of the Northwest Kidney Centers.","The Northwest Kidney Center (NWC) in Seattle, Washington, has been a leader in nephrology care for almost 60 years, opening the first hemodialysis unit in the United States in 1962. In February 2020, one of their patients was the first reported death from COVID-19 in the United States. On April 6, 2020, as a part of NNJ Extra - the Nephrology Nursing Journal's podcast series, Beth Ulrich, EdD, RN, FACHE, FAONL, FAAN, Editor-in-Chief of the Nephrology Nursing Journal, talked with the leaders of the Northwest Kidney Centers - Suzanne Watnick, MD, the Chief Medical Officer, and Liz McNamara, MN, RN, Vice President of Patient Care Services and the Chief Nursing Officer, who discussed dealing with the onset of COVID-19 at NWC, how their team worked together to provide care for their patients and support for their staff members, and the lessons they learned that can benefit others.","Nephrol Nurs J","Ulrich, Beth","McNamara, Liz","Watnick, Suzanne","Last, First Middle","32343085"],"abstract":["The Northwest Kidney Center (NWC) in Seattle, Washington, has been a leader in nephrology care for almost 60 years, opening the first hemodialysis unit in the United States in 1962. In February 2020, one of their patients was the first reported death from COVID-19 in the United States. On April 6, 2020, as a part of NNJ Extra - the Nephrology Nursing Journal's podcast series, Beth Ulrich, EdD, RN, FACHE, FAONL, FAAN, Editor-in-Chief of the Nephrology Nursing Journal, talked with the leaders of the Northwest Kidney Centers - Suzanne Watnick, MD, the Chief Medical Officer, and Liz McNamara, MN, RN, Vice President of Patient Care Services and the Chief Nursing Officer, who discussed dealing with the onset of COVID-19 at NWC, how their team worked together to provide care for their patients and support for their staff members, and the lessons they learned that can benefit others."],"journal":"Nephrol Nurs J","authors":["Ulrich, Beth","McNamara, Liz","Watnick, Suzanne","Last, First Middle"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32343085","source":"PubMed","week":"202018|Apr 27 - May 03","keywords":["covid-19","collaboration","coronavirus","dialysis","hemodialysis","home hemodialysis","infectious disease","nephrology nurses","peritoneal dialysis"],"locations":["Seattle","Washington","United States","United States"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1666138495083610113,"score":110.16541},{"pmid":32204907,"pmcid":"PMC7133222","title":"The Novel Coronavirus 2019 epidemic and kidneys.","text":["The Novel Coronavirus 2019 epidemic and kidneys.","Kidney Int","Naicker, Saraladevi","Yang, Chih-Wei","Hwang, Shang-Jyh","Liu, Bi-Cheng","Chen, Jiang-Hua","Jha, Vivekanand","32204907"],"journal":"Kidney Int","authors":["Naicker, Saraladevi","Yang, Chih-Wei","Hwang, Shang-Jyh","Liu, Bi-Cheng","Chen, Jiang-Hua","Jha, Vivekanand"],"date":"2020-03-25T11:00:00Z","year":2020,"_id":"32204907","source":"PubMed","week":"202013|Mar 23 - Mar 29","doi":"10.1016/j.kint.2020.03.001","keywords":["acute kidney injury","hemodialysis"],"topics":["Diagnosis","Treatment","Prevention"],"weight":1,"_version_":1666138490139574273,"score":96.93849},{"pmid":32479921,"title":"Kidney Infarction in Patients With COVID-19.","text":["Kidney Infarction in Patients With COVID-19.","Coronavirus disease 2019 (COVID-19) is a contagious, life-threatening infection caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Recent findings indicate an increased risk of acute kidney injury during COVID-19. The pathophysiological mechanisms leading to acute kidney injury in COVID-19 are unclear, but may include direct cytopathic effects of the virus on kidney tubular and endothelial cells, indirect damage caused by virus-induced cytokine release, and kidney hypoperfusion due to a restrictive fluid strategy. In this case-report we propose an additional pathophysiological mechanism. We describe two cases in which patients with COVID-19 developed a decrease in kidney function due to kidney infarction. These patients did not have atrial fibrillation. One of these patients was treated with therapeutic doses of low molecular weight heparin, whereafter no further deterioration of kidney function was observed. Our findings implicate that the differential diagnosis of acute kidney injury in COVID-19 patients should include kidney infarction, which may have important preventive and therapeutic implications.","Am J Kidney Dis","Post, Adrian","den Deurwaarder, Edwin S G","Bakker, Stephan J L","de Haas, Robbert J","van Meurs, Matijs","Gansevoort, Ron T","Berger, Stefan P","32479921"],"abstract":["Coronavirus disease 2019 (COVID-19) is a contagious, life-threatening infection caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Recent findings indicate an increased risk of acute kidney injury during COVID-19. The pathophysiological mechanisms leading to acute kidney injury in COVID-19 are unclear, but may include direct cytopathic effects of the virus on kidney tubular and endothelial cells, indirect damage caused by virus-induced cytokine release, and kidney hypoperfusion due to a restrictive fluid strategy. In this case-report we propose an additional pathophysiological mechanism. We describe two cases in which patients with COVID-19 developed a decrease in kidney function due to kidney infarction. These patients did not have atrial fibrillation. One of these patients was treated with therapeutic doses of low molecular weight heparin, whereafter no further deterioration of kidney function was observed. Our findings implicate that the differential diagnosis of acute kidney injury in COVID-19 patients should include kidney infarction, which may have important preventive and therapeutic implications."],"journal":"Am J Kidney Dis","authors":["Post, Adrian","den Deurwaarder, Edwin S G","Bakker, Stephan J L","de Haas, Robbert J","van Meurs, Matijs","Gansevoort, Ron T","Berger, Stefan P"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32479921","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1053/j.ajkd.2020.05.004","keywords":["acute kidney injury","covid-19","kidney infarction","sars-cov-2","anticoagulation"],"topics":["Case Report"],"weight":1,"_version_":1668437835022073857,"score":64.65946}]}